Cleveland Clinic Abu Dhabi Cancer Institute

The Cleveland Clinic Abu Dhabi Cancer Institute (Fatima bint Mubarak Center) plays a comprehensive role in advancing cancer control across the UAE and the region through an integrated, patient-centered model aligned with global best practices. The Institute contributes to prevention and risk reduction through lifestyle medicine programs, public awareness, and hereditary high-risk clinics that support genetic counseling and early intervention for at-risk populations. In early detection, it leverages advanced technologies such as AI-supported imaging and precision diagnostics to identify cancers at earlier, more treatable stages. A key strength lies in its multidisciplinary care model, where tumor boards bring together specialists across oncology, surgery, radiology, pathology, and genetics to ensure accurate diagnosis and evidence-based treatment planning. The Institute provides comprehensive treatment services, including medical oncology, radiation therapy, hematology, and access to advanced therapies such as immunotherapy, genomic-driven precision medicine, and minimally invasive surgery. Through its integration with the global Cleveland Clinic network, the Institute supports research and innovation, including participation in international clinical trials, thereby strengthening regional capacity for evidence generation and innovation in cancer care. The Institute also prioritizes survivorship and supportive care, offering palliative services, psychosocial support, and patient-centered programs that enhance quality of life and long-term outcomes. Importantly, it contributes to health system strengthening by building local expertise, reducing reliance on overseas treatment, and establishing internationally benchmarked oncology services within the UAE. Overall, the Cancer Institute contributes across the full cancer control continuum—from prevention and early detection to treatment, research, and survivorship—aligning with the global mission of the UICC.